Effective prevention and treatment of disease depend on accurate knowledge about the causes of disease, on information about how disease affects the body, on drugs that combat disease, on devices that work, and on operations that cure. The knowledge, material, and skills on which prevention and treatment are based have come from a wide variety of sources, including basic scientific disciplines such as chemistry, biology, physics, engineering, and mathematics; observation of naturally occurring disease in human and animal populations; and experimentation on human subjects and animals.
As a result of research, prevention, and educational programs, advances have been made in the battle against cardiovascular diseases and stroke. However, these diseases remain the leading causes of death in the United States. The plummeting death rate from coronary heart disease and stroke is related to both lifestyle changes and the development of methods of treatment, many of which are based on animal experimentation.
We have no cure for most of these diseases, and the reduced mortality is presenting us with the enormous challenge of caring for an ever-increasing population of patients with severe cardiovascular disabilities. We are at the threshold of major discoveries that promise a cure but that cannot go on without animal research. Currently, there is no satisfactory way besides the animal model to reproduce the extraordinary complexity of the human cardiovascular system. Therefore, creation of new knowledge about the cause of cardiovascular disease, the testing of new drugs, and the refinement of new devices and operations affecting this area require animal experimentation.
The American Heart Association (AHA) takes the position that the responsible use of animals is essential and necessary to biomedical research and education in the prevention, reduction, and treatment of diseases of the heart and blood vessels.
As a founding meniber of the American Association for Accreditation of Laboratory Animal Care (AAALAC), the AHA has been in the forefront of strongly endorsing responsible and humane use of animals in biomedical research. No Working closely with the NABR during the 6-year public comment period, the AHA submitted four sets of comments to the USDA about the effects of these proposals on biomedical research. The AHA's comments on part 3 were instrumental in convincing the USDA to change the proposed standards from rigid engineering standards to a mixture of minimum requirements and performance-based standards. The resulting rules, finalized in February 1991 and costing some $500 million, provide baseline standards with which all facilities must comply but recognize that professional judgment must be exercised in individual cases.
The USDA performance-based rules dealing with dogs and nonhuman primates (part 3) were 
